These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 10197618)
1. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo. Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618 [TBL] [Abstract][Full Text] [Related]
2. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors. Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338 [TBL] [Abstract][Full Text] [Related]
3. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product. Adamson AL; Kenney SC Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP. Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396 [TBL] [Abstract][Full Text] [Related]
5. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies. Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors. Feng WH; Israel B; Raab-Traub N; Busson P; Kenney SC Cancer Res; 2002 Mar; 62(6):1920-6. PubMed ID: 11912175 [TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer. Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287 [TBL] [Abstract][Full Text] [Related]
9. In situ RT-PCR detection of Epstein-Barr virus immediate-early transcripts in CD4+ and CD8+ T lymphocytes. Guan M; Romano G; Henderson EE Anticancer Res; 1998; 18(5A):3171-80. PubMed ID: 9858880 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1. Jung YJ; Choi H; Kim H; Lee SK J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173 [TBL] [Abstract][Full Text] [Related]
11. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182 [TBL] [Abstract][Full Text] [Related]
12. Latent and lytic Epstein-Barr virus replication strategies. Tsurumi T; Fujita M; Kudoh A Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591 [TBL] [Abstract][Full Text] [Related]
13. H2O2 inhibits BCR-dependent immediate early induction of EBV genes in Burkitt's lymphoma cells. Osipova-Goldberg HI; Turchanowa LV; Adler B; Pfeilschifter JM Free Radic Biol Med; 2009 Oct; 47(8):1120-9. PubMed ID: 19540913 [TBL] [Abstract][Full Text] [Related]
14. A molecular link between malaria and Epstein-Barr virus reactivation. ChĂȘne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 alter mitochondrial morphology during lytic replication. LaJeunesse DR; Brooks K; Adamson AL Biochem Biophys Res Commun; 2005 Jul; 333(2):438-42. PubMed ID: 15950179 [TBL] [Abstract][Full Text] [Related]
16. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin. Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034 [TBL] [Abstract][Full Text] [Related]
17. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma. Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420 [TBL] [Abstract][Full Text] [Related]
18. Aspirin induces lytic cytotoxicity in Epstein-Barr virus-positive cells. Liu SF; Wang H; Li ZJ; Deng XY; Xiang H; Tao YG; Li W; Tang M; Cao Y Eur J Pharmacol; 2008 Jul; 589(1-3):8-13. PubMed ID: 18571159 [TBL] [Abstract][Full Text] [Related]
19. The nitroreductase/CB1954 combination in Epstein-Barr virus-positive B-cell lines: induction of bystander killing in vitro and in vivo. Westphal EM; Ge J; Catchpole JR; Ford M; Kenney SC Cancer Gene Ther; 2000 Jan; 7(1):97-106. PubMed ID: 10678362 [TBL] [Abstract][Full Text] [Related]
20. Immune activation suppresses initiation of lytic Epstein-Barr virus infection. Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]